Altamira Therapeutics reported total assets of $7.13M and total liabilities of $3.06M for the quarter ended Jun 2025, up 3.3% year over year. This balance sheet covers 17 quarters of results from Dec 2016 through Jun 2025, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Dec2016 | Dec2017 | Dec2018 | Jun2019 | Dec2019 | Jun2020 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jan2023 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Current Assets | |||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 31.90M | 15.30M | 5.48M | 5.93M | 1.43M | 0.04M | 12.77M | 9.19M | 1.08M | 0.39M | 0.02M | 0.02M | 0.06M | 0.73M | 0.07M | 1.00M | 0.00M |
| Short-term InvestmentsInvestments (Current) | 28.92M | ||||||||||||||||
| Cash & Current Investments | 31.90M | 15.30M | 5.48M | 5.93M | 1.43M | 0.04M | 12.77M | 9.19M | 1.08M | 0.39M | 0.02M | 0.02M | 28.97M | 0.73M | 0.07M | 1.00M | 0.00M |
| Receivables - NetNet Receivables | 0.33M | 0.31M | 0.35M | 0.16M | 0.09M | 0.15M | 0.73M | 0.47M | 0.01M | 0.01M | 0.04M | ||||||
| Receivables - OtherOther Receivables | 0.73M | 0.82M | 0.09M | 0.35M | |||||||||||||
| Receivables | 0.33M | 0.31M | 0.35M | 0.16M | 0.09M | 0.15M | 1.47M | 0.47M | 0.83M | 0.01M | 0.04M | ||||||
| Inventory | 0.21M | 0.92M | 0.15M | 0.01M | 0.01M | 0.30M | |||||||||||
| Prepaid Assets | 0.04M | 0.01M | 1.57M | 0.72M | 0.25M | 0.19M | |||||||||||
| Current Assets | 33.12M | 16.21M | 6.17M | 6.47M | 2.45M | 0.41M | 13.18M | 9.93M | 4.48M | 2.02M | 1.92M | 1.91M | 1.92M | 1.45M | 0.52M | 1.54M | 0.25M |
| Non-Current Assets | |||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.36M | 0.26M | 0.03M | 0.02M | 0.07M | 0.06M | 0.05M | 0.02M | 1.09 | 1.05 | 1.08 | 1.00 | 1.11 | 1.19 | 1.00 | 0.10M | 0.10M |
| Goodwill | 2.92M | 2.71M | |||||||||||||||
| Intangibles | 1.46M | 1.66M | 3.59M | 5.28M | 6.98M | 7.89M | 10.34M | 15.79M | 15.67M | 16.61M | 4.22M | 4.21M | 4.33M | 4.62M | 4.63M | 4.63M | 4.63M |
| Goodwill & Intangibles | 1.46M | 1.66M | 3.59M | 5.28M | 6.98M | 7.89M | 10.34M | 15.79M | 15.67M | 16.61M | 4.22M | 4.21M | 4.33M | 7.54M | 4.63M | 7.34M | 4.63M |
| Long-Term Deferred Tax | 0.31M | 0.15M | 0.09M | 0.08M | 0.54M | 0.16M | 0.03M | 0.03M | 0.04M | 0.04M | |||||||
| Other Non-Current Assets | 0.10M | 0.12M | |||||||||||||||
| Non-Current Assets | 1.93M | 2.00M | 3.88M | 5.55M | 7.07M | 7.96M | 10.42M | 15.84M | 16.50M | 17.35M | 4.91M | 4.90M | 4.98M | 7.67M | 7.55M | 7.11M | 6.88M |
| Assets | 35.06M | 18.21M | 10.04M | 12.01M | 9.52M | 8.37M | 23.59M | 25.77M | 20.98M | 19.37M | 6.83M | 6.81M | 6.90M | 9.12M | 8.07M | 8.65M | 7.13M |
| Liabilities | |||||||||||||||||
| Current Liabilities | |||||||||||||||||
| Accounts Payables | 1.81M | 1.23M | 1.87M | 0.86M | 0.97M | 1.32M | 0.86M | 1.60M | 4.05M | 3.32M | 5.33M | 5.31M | 2.18M | 0.52M | 0.53M | 0.55M | 0.76M |
| Notes Payables | 1.46M | 0.05M | 0.59M | ||||||||||||||
| Payables | 1.81M | 1.23M | 3.33M | 0.86M | 0.97M | 1.37M | 1.46M | 1.60M | 4.05M | 3.32M | 5.33M | 5.31M | 2.18M | 0.52M | 0.53M | 0.55M | 0.76M |
| Accumulated Expenses | 1.31M | 0.97M | 1.38M | 1.23M | 1.63M | 1.15M | 2.14M | 0.41M | |||||||||
| Short term Debt | 2.18M | 4.64M | 1.46M | 0.59M | 0.13M | 4.93M | 6.49M | 6.35M | 3.40M | 0.12M | 0.43M | ||||||
| Total Current Liabilities | 8.81M | 10.65M | 4.64M | 1.83M | 2.35M | 2.55M | 3.44M | 3.33M | 5.32M | 10.26M | 13.96M | 13.92M | 5.97M | 1.05M | 1.23M | 1.16M | 2.31M |
| Non-Current Liabilities | |||||||||||||||||
| Non-Current Debt | 9.98M | 5.71M | |||||||||||||||
| Non-Current Deferred Tax LiabilityNon-Current Deferred Tax | 0.19M | 0.18M | 0.35M | 0.15M | 0.14M | 0.13M | 0.16M | 0.10M | 0.14M | 0.14M | 0.14M | ||||||
| Operating Leases | 0.51M | 0.42M | 0.37M | 0.37M | 0.32M | 0.30M | 0.24M | 0.20M | |||||||||
| Total Non-Current Liabilities | 12.35M | 9.77M | 1.69M | 1.02M | 0.94M | 1.12M | 1.13M | 0.63M | 1.39M | 2.04M | 1.88M | 1.88M | 2.96M | 0.41M | 0.52M | 0.92M | 0.75M |
| Total Liabilities | 21.15M | 20.42M | 6.33M | 2.85M | 3.29M | 3.66M | 4.57M | 3.96M | 6.71M | 12.30M | 15.84M | 15.80M | 8.93M | 1.47M | 1.75M | 2.09M | 3.06M |
| Shareholder's Equity | |||||||||||||||||
| Total Debt | 12.16M | 10.35M | 1.46M | 0.05M | 0.59M | 0.13M | 4.93M | 6.63M | 6.35M | 3.40M | 0.12M | 0.43M | |||||
| Common Equity | 13.91M | -2.21M | 3.71M | 9.17M | 6.23M | 4.71M | 19.02M | 21.81M | 14.27M | 7.07M | -9.01M | -8.99M | -2.03M | 7.66M | 6.32M | 6.57M | 4.07M |
| Liabilities and Shareholders Equity | 35.06M | 18.21M | 10.04M | 12.01M | 9.52M | 8.37M | 23.59M | 25.77M | 20.98M | 19.37M | 6.83M | 6.81M | 6.90M | 9.12M | 8.07M | 8.65M | 7.13M |
| Retained Earnings | -110.46M | -139.09M | -148.74M | -153.29M | -157.73M | -163.34M | -182.21M | -179.08M | -192.28M | -192.35M | -218.27M | -226.26M | -22.07M | -21.40M | 1.26M | -3.03M | -4.04M |
Pull Altamira Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CYTOF&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CYTOF", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CYTOF&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();